In the rapidly evolving realm of flow cytometry, conventional flow cytometry is gradually being displaced by its advanced counterpart, spectral flow cytometry. These technologies, each with its unique strengths and applications, have revolutionized the way we analyze cells and particles. Let’s dive into the distinctions between these two methodologies, uncovering the reasons behind their coexistence and why spectral flow cytometry might just hold the key to the future.
Understanding the Basics: Conventional vs. Spectral Flow Cytometry
Conventional flow cytometry, a long-standing pillar of cellular analysis, employs a range of lasers to excite cell-bound fluorophores. These fluorophores generate shifted fluorescence signals that are screened by filters and captured by light detectors, enabling researchers to distinguish up to 25 to 30 colors when using optimal dye and filter sets.
Spectral flow cytometry operates on a similar laser foundation, however, what truly sets it apart is its innovative use of 40 to 80 detectors. This multitude of detectors captures fluorescence signals simultaneously, creating a comprehensive spectral fingerprint of the sample. To draw an analogy, conventional flow cytometry is similar to taking a snapshot of a moment, while spectral flow cytometry is comparable to capturing an entire video.
The Case for Conventional Flow Cytometry
Despite the emergence of spectral flow cytometry, conventional technology maintains its relevance, mainly due to its established legacy and large base of installed systems. For long-term studies or projects heavily invested in conventional platforms, sticking to the tried-and-true can reduce development costs and streamline workflows. However, the tide is turning, and many experts believe that the advantages of spectral flow cytometry far outweigh those of its conventional counterpart.
Spectral flow cytometry is the natural progression in cellular analysis. While it can perform all that conventional flow cytometry can, its superiority lies in its ability to deliver enhanced data quality. The simultaneous collection of a multitude of signals enables a holistic view of cellular features, making it equivalent to having an entire sports team on the field rather than a single player. This translates to more comprehensive and accurate insights, crucial for research and clinical applications.
Navigating the Path Forward in Spectral Flow Cytometry
Underpinned by years of experience, FlowMetric, a KCAS company, stands out in the realm of spectral flow cytometry. Our competitive edge stems from the redundancy of our platform – a vital insurance against instrument downtime. Unlike competitors who rely on single platforms, we ensure continuous operation to avoid lengthy delays in the analysis of live samples.
Moreover, our team of experts boasts significant experience with spectral flow cytometry. Our team has been at the forefront of this technology’s evolution, using and employing spectral flow for as long as the technique has been around. Our seasoned professionals have closely tracked its progress, mastering the instruments, software, and analytical techniques in tandem with their commercial development. This ability to make cutting edge techniques part of a standard practice is what continues to set us apart from others who aren’t able to incorporate a higher level of complexity into their workflows.
As a powerhouse in both conventional and spectral flow cytometry, we offer more than just data analysis; we provide guidance from the outset. Our deep understanding of the technologies allows us to recommend the optimal approach for each project, ensuring that our clients harness the right tools to answer their questions effectively.
Whether it’s conventional flow cytometry, spectral flow cytometry, ELISPOT, or isoplexis, we can recommend the right technology to answer the questions that they have. We empower clients to make informed decisions, enabling them to embark on research journeys with the right tools at their disposal.
Our commitment to excellence is reflected in the instrumentation we employ. For conventional flow cytometry in our Philadelphia and Lyon sites, we rely on the BD LSRFortessa platform – a trusted workhorse in the field. For cutting-edge spectral flow cytometry, we leverage the Cytek Aurora platform, harnessing its power to unlock new dimensions of data quality and insight.
Experience the Future of Cellular Analysis
In the ever-evolving landscape of flow cytometry, spectral flow cytometry emerges as the beacon of progress. Its ability to provide holistic, high-quality data promises to reshape research and clinical analysis. As we continue to lead the charge in this domain, we invite you to embark on a conversation with us.
If you’re ready to harness the transformative power of spectral flow cytometry, FlowMetric, a KCAS company, is your partner of choice. Our expertise, state-of-the-art instruments, and commitment to excellence position us as the industry leader in cellular analysis. Contact us today to start a conversation about your flow cytometry project and unlock new realms of insight.
If you have any questions about these services or any others offered by KCAS, please use the form below. Thank you!